BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease

International Journal of Medical Sciences

Volumn 4, Issue 3, 2007, Pages 140-145

  Evans, Teresa A ^a   Raina, Arun K ^a   Delacourte, André ^b   Aprelikova, Olga ^c   Lee, Hyoung Gon ^a   Zhu, Xiongwei ^a   Perry, George ^a,d   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d University of San Antonio   (United States)

Author keywords

Alzheimer disease; BRCA1; Cell cycle; Oncogenesis

Indexed keywords

BRCA1 PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL CYCLE REGULATION; HUMAN; NERVE CELL; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROMODULATION; PHENOTYPE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

EID: 34248345577     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.4.140     Document Type: Article

References (44)

1. Grundke-Iqbal I, Iqbal K, Tung YC, et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986; 83: 4913-7.
2. Perry G, Rizzuto N, Autilio-Gambetti L, et al. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc Natl Acad Sci U S A 1985; 82: 3916-20.
3. Mori H, Kondo J, Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 1987; 235: 1641-4.
4. Perry G, Friedman R, Shaw G, et al. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci U S A 1987; 84: 3033-6.
5. Perry G, Cras P, Siedlak SL, et al. Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 1992; 140: 283-90.
6. Ogawa O, Lee HG, Zhu X, et al. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell 2003; 2: 105-10.
7. Ogawa O, Zhu X, Lee HG, et al. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol (Berl) 2003; 105: 524-8.
8. McShea A, Harris PL, Webster KR, et al. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 1997; 150: 1933-9.
9. Nagy Z, Esiri MM, Cato AM, et al. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (Berl) 1997; 94: 6-15.
10. Nagy Z, Esiri MM, Smith AD. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (Berl) 1997; 93: 294-300.
11. Vincent I, Rosado M, Davies P. Mitotic mechanisms in Alzheimer's disease? J Cell Biol 1996; 132: 413-25.
12. Castellani RJ, Lee HG, Zhu X, et al. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathol (Berl) 2006; 111: 503-9.
13. Korhonen L, Brannvall K, Skoglosa Y, et al. Tumor suppressor gene BRCA-1 is expressed by embryonic and adult neural stem cells and involved in cell proliferation. J Neurosci Res 2003; 71: 769-76.
14. Gabbita SP, Lovell MA, Markesbery WR. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem 1998; 71: 2034-40.
15. Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999; 19: 1959-64.
16. Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60: 759-67.
17. Su JH, Deng G, Cotman CW. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res 1997; 774: 193-9.
18. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994; 36: 747-51.
19. Somasundaram K. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair - perhaps through transcription. J Cell Biochem 2003; 88: 1084-91.
20. Gartner U, Holzer M, Arendt T. Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience 1999; 91: 1-5.
21. Raina AK, Hochman A, Zhu X, et al. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol (Berl) 2001; 101: 305-10.
22. Suzuki A, Tsutomi Y, Akahane K, et al. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 1998; 17: 931-9.
23. Eymin B, Sordet O, Droin N, et al. Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity. Oncogene 1999; 18: 4839-47.
24. Blagosklonny MV. Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 2002; 1: 391-3.
25. Rahman N, Stratton MR. The genetics of breast cancer susceptibility. Annu Rev Genet 1998; 32: 95-121.
26. Chapman MS, Verma IM. Transcriptional activation by BRCA1. Nature 1996; 382: 678-9.
27. Holt JT, Thompson ME, Szabo C, et al. Growth retardation and tumour inhibition by BRCA1. Nat Genet 1996; 12: 298-302.
28. Monteiro AN, August A, Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci U S A 1996; 93: 13595-9.
29. Gowen LC, Avrutskaya AV, Latour AM, et al. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 1998; 281: 1009-12.
30. Scully R, Chen J, Ochs RL, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997; 90: 425-35.
31. Hsu LC, White RL. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A 1998; 95: 12983-8.
32. Chen Y, Chen CF, Riley DJ, et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 1995; 270: 789-91.
33. Mecocci P. Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. J Alzheimers Dis 2004; 6: 159-63.
34. Raina AK, Garrett MR, Previll LA, et al. Oncogenic parallels in Alzheimer disease. Int J Neuroprotec Neuroregen 2006; 2: 80-5.
35. Zhu X, Castellani RJ, Takeda A, et al. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech Ageing Dev 2001; 123: 39-46.
36. Zhu X, Raina AK, Perry G, et al. Alzheimer's disease: the two-hit hypothesis. Lancet Neurol 2004; 3: 219-26.
37. Zhu X, Lee HG, Perry G, et al. Alzheimer disease, the two-hit hypothesis: An update. Biochim Biophys Acta 2007;1772:494-502
38. Webber KM, Raina AK, Marlatt MW, et al. The cell cycle in Alzheimer disease: a unique target for neuropharmacology. Mech Ageing Dev 2005; 126: 1019-25.
39. Okada S, Ouchi T. Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization. J Biol Chem 2003; 278: 2015-20.
40. Coene ED, Hollinshead MS, Waeytens AA, et al. Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Mol Biol Cell 2005; 16: 997-1010.
41. McPherson JP, Hande MP, Poonepalli A, et al. A role for Brca1 in chromosome end maintenance. Hum Mol Genet 2006; 15: 831-8.
42. Franco S, Blasco MA, Siedlak SL, et al. Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy? Alzheimers Dementia 2006; 2: 164-8.
43. Keimowitz RM. Dementia improvement with cytotoxic chemotherapy. A case of Alzheimer disease and multiple myeloma. Arch Neurol 1997; 54: 485-8.
44. Woods J, Snape M, Smith MA. The cell cycle hypothesis of Alzheimer's disease: Suggestions for drug development. Biochim Biophys Acta 2007; 1772: 503-8.